Laboratory of Autoimmunity, Section of Experimental Pathophysiology and Immunology, Biocenter, Innsbruck Medical University, Fritz-Pregl-Strasse 3, Schöpfstraße 41/1, A-6020 Innsbruck, Austria.
J Autoimmun. 2012 Dec;39(4):441-50. doi: 10.1016/j.jaut.2012.07.006. Epub 2012 Aug 15.
Atherosclerosis is a multifactorial chronic inflammatory disease characterized by the presence of T-cells, macrophages, and dendritic cells in the arterial intima. Classical risk factors lead to over-expression of stress proteins, especially heat shock protein 60 (HSP60). HSP60 on the surface of arterial endothelial cells (ECs) then becomes a target for pre-existing adaptive anti-HSP60 immunity resulting in infiltration of the intima by mononuclear cells. In the present study, T-cells derived from early, clinically still inapparent human atherosclerotic lesions were analyzed phenotypically and for their reactivity against HSP60 and HSP60-derived peptides. HSP60 was detected in ECs and CD40- and HLA Class II-positive cells within the intima. Effector memory CD4(+) T-cells producing high amounts of interferon-γ and low levels of interleukin-4 were the dominant subpopulation. T-cells derived from late lesions displayed a more restricted T-cell receptor repertoire to HSP60-derived peptides than those isolated from early lesions. Increased levels of soluble HSP60 and circulating anti-human HSP60 autoantibodies were found in donors with late but not early lesions. This is the first functional study of T-cells derived from early human atherosclerotic lesions that supports the previously proposed concept that HSP60-reactive T-cells initiate atherosclerosis by recognition of atherogenic HSP60 epitopes.
动脉粥样硬化是一种多因素的慢性炎症性疾病,其特征是 T 细胞、巨噬细胞和树突状细胞存在于动脉内膜中。经典的危险因素导致应激蛋白,尤其是热休克蛋白 60(HSP60)的过度表达。动脉内皮细胞(ECs)表面的 HSP60 随后成为预先存在的适应性抗 HSP60 免疫的靶标,导致单核细胞浸润内膜。在本研究中,分析了源自早期、临床上仍无症状的人类动脉粥样硬化病变的 T 细胞的表型,并分析了它们对 HSP60 和 HSP60 衍生肽的反应性。在 ECs 和内膜中 CD40-和 HLA Ⅱ类阳性细胞中检测到 HSP60。产生大量干扰素-γ和低水平白细胞介素-4 的效应记忆 CD4(+) T 细胞是主要亚群。与源自早期病变的 T 细胞相比,源自晚期病变的 T 细胞对 HSP60 衍生肽的 T 细胞受体谱更为受限。在晚期病变但不是早期病变的供体中发现可溶性 HSP60 水平升高和循环抗人 HSP60 自身抗体。这是首次对源自人类早期动脉粥样硬化病变的 T 细胞进行的功能研究,支持了先前提出的 HSP60 反应性 T 细胞通过识别动脉粥样硬化 HSP60 表位引发动脉粥样硬化的概念。